The Texas Rangers' offseason has been an epic failure based on what they told us they wanted to accomplish.

A report linking Rangers outfielder Nelson Cruz to PEDs rocked an already wobbly Rangers offseason. Steven Bisig/USA TODAY Sports

Well, it became a lot worse on Tuesday, when a report in the Miami New Times linked right fielder Nelson Cruz to Biogenesis of America, a Miami-based anti-aging company that has been called the BALCO of the East Coast.

BALCO, you remember, is the company slugger Barry Bonds, track superstar Marion Jones and others made famous thanks to Victor Conte's performance-enhancing drugs that seemed to make mind-blowing performances routine.

Yikes.

Cruz, an all-around good guy nicknamed "Boomstick," is now one of the central characters in a PED scandal. Just so you know, Major League Baseball can impose a 50-game suspension regardless of whether a player has ever flunked a drug test. It just needs to prove that the player has possessed PEDs.

Lance Armstrong has taught us all that passing a million drug tests means nothing in the world of PEDs. The users are always ahead of the testers.

The Rangers should expect this to get worse before it gets better. They should already be putting their contingency plan in place, so if Cruz gets popped for 50 games -- the punishment for a first-time offense of the league's PED policy -- they can handle the suspension as smoothly as possible.

The Rangers and MLB each released statements Tuesday that shed little light on the scandal in general and Cruz in particular.

Don't expect to hear from Cruz for a while.

This is particularly bad news for the Rangers, who've had a forgettable offseason. They failed to sign Zack Greinke in free agency or trade for Justin Upton.

The team wanted to re-sign center fielder Josh Hamilton -- an awful idea, considering he quit on the club three times in the last three weeks of the season. Still, general manager Jon Daniels seemed genuinely surprised the day Hamilton's deal went down.

Then Ian Kinsler decided he didn't want to move to first base after all, which meant the Rangers suddenly had no room in the infield for Jurickson Profar, who's only considered one of the top prospects in baseball.